Neoadjuvant Stereotactic Ablative Radiotherapy for Pancreatic Ductal Adenocarcinoma

Clinical trial NCT04915417 · UNKNOWN

Trial details

NCT number: NCT04915417
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Resectable Pancreatic Adenocarcinoma Borderline Resectable Pancreatic Adenocarcinoma

Start date: 2021-08-01
Primary completion: 2023-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.